Log In
BCIQ
Print this Print this
 

MelCancerVac

  Manage Alerts
Collapse Summary General Information
Company DanDrit Biotech USA Inc.
DescriptionAllogeneic tumor lysate-based cancer vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase III
Standard IndicationColorectal cancer
Indication DetailsTreat colorectal cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today